Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM further positions the company as a global leader in diagnostic imaging in radiology and cardiology. The merger allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents. The synergies among both companies' product portfolios, complementary customer bases and technical expertise will strengthen Bracco Diagnostics' position in the evolving field of imaging informatics and patient management.
If you enjoy this content, please share it with a colleague
Related Content
March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...
March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...
March 11, 2026 — Royal Philips has announced the expansion of its digital pathology portfolio with new cloud-enabled ...
March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...
March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...
March 1, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that practice turnover (i.e ...
March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...
March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...
March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...
Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has ...
March 30, 2026 